5Gonzalez-Barcena D, Vadillo-Buenfil M, Cortez Morales A, et al. Luteinizing hormone-releasing hormone antagonist cetrorelix as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord. Urology, 1995,45(2) : 275-281.
6[1]Montgomery BE,Daum GS,Dunton CJ Endometrial hyperplasia:a review[J].Obstet Gynecol Surv,2004; 59(5):368.
7[2]Jadoul P,Donnez J.Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenoearcinoma[J].Fertil Steri,2003,80(6):1315.
8[6]Agorastos T,Vaitsi V,Paschopoulos M,et al Prolonged use of gonadotropin-releasing hormone agonist and tibolone as add-back therapy for the treatment of endometrial hyperplasia[J].Maturitas,2004,15 ;48 (2):125.
9Trope CG, Marth C, Scheistroen M, Abeler VM.Endometrial hyperplasia-diagnosis and treatment (see comments).Tidsskr Nor Laegeforen 1999 may 30, 119 (14):2030 ～2034
